Women in Oncology: How Has the Culture of Oncology Practice Changed Regarding Gender Disparities?

Video

Laura Farrington, DO, Elesyia Outlaw-Evans, MD, and Ruchi Garg, MD, share insight on how the corporate culture has changed in oncology practices with regard to gender inequality.

Laura Farrington, DO, a medical oncologist at CTCA Chicago; Elesyia Outlaw-Evans, MD, a radiation oncologist at CTCA Pheonix; and Ruchi Garg, MD, CTCA Program Director of Gynecologic Oncology and gynecologic oncologist at CTCA Atlanta, share insight on how the corporate culture has changed in oncology practices with regard to gender inequality.

The 3 experts sat down to be candid and discuss their variety of experiences throughout their career, what the culture of their work environments were like, the obstacles they came into contact with and how they overcame them, and how society has changed from their early days until now.

Notably, in this exclusive interview, they highlight advice to up-and-upcoming female oncologists on navigating these waters today.

In this episode, the 3 experts discuss in detail how they believe the corporate culture of oncology practices have evolved over the years as it relates to gender-related disparities, and what work still needs to be done in this area.


Related Videos
Mike Lattanzi, MD, medical oncologist, Texas Oncology
Vikram M. Narayan, MD, assistant professor, Department of Urology, Emory University School of Medicine, Winship Cancer Institute; director, Urologic Oncology, Grady Memorial Hospital
Stephen V. Liu, MD
S. Vincent Rajkumar, MD
Pashtoon Murtaza Kasi, MD, MS
Naseema Gangat, MBBS
Samilia Obeng-Gyasi, MD, MPH,
Kian-Huat Lim, MD, PhD
Saurabh Dahiya, MD, FACP, associate professor, medicine (blood and marrow transplantation and cellular therapy), Stanford University School of Medicine, clinical director, Cancer Cell Therapy, Stanford BMT and Cell Therapy Division
Muhamed Baljevic, MD